Hydrocephalus Clinical Trials 2023

Hydrocephalus Clinical Trials 2023

Hydrocephalus research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in hydrocephalus clinical trials today.

Popular filter options for hydrocephalus trials

Hydrocephalus Clinical Trials With No Placebo

View 9 hydrocephalus medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hydrocephalus

What are the top hospitals conducting hydrocephalus research?

In the realm of hydrocephalus, several leading hospitals are spearheading groundbreaking clinical trials to improve the lives of those affected by this condition. One such institution is Texas Children's Hospital in Houston, where researchers are currently conducting two active trials for hydrocephalus. Over time, they have contributed to a total of eight trials since their first recorded investigation in 2008. Similarly, Yale University in New Haven has also made significant strides with their two ongoing hydrocephalus trials. Although they have only conducted a total of two studies thus far, their commitment to advancing knowledge and treatment options for this condition is evident from their first recorded trial in 2022.

Meanwhile, at the renowned Mayo Clinic located in Rochester, Minnesota, researchers are actively engaged in two clinical trials focused on hydrocephalus. While their journey has just begun with only two previous investigations conducted since 2019, they bring expertise and dedication to unraveling the complexities surrounding this neurological disorder.

Notably contributing to this field as well is Montefiore Medical Center Department of Neurosurgery situated in New york City. With one active trial underway and boasting a single completed study historically dating back to 2022 when it began its pioneering work on hyrdoephalus; there is promise and potential for further advancements within these walls.

Furthermore joining these efforts is the University at Buffalo located amidst picturesque Buffalo which similarly dedicates itself towards understanding hydrocephalus through an ongoing trial alongside another experiment previously held that can be traced back merely ten years ago starting from 2022.

These hospitals represent beacons of hope for individuals living with hydrocephalus while serving as epicenters for medical innovation across various regions within the United States.Key developments generated by these institutions hold tremendous potential not just locally but globally as well - driving us closer towards improved treatments and enhanced quality of life for those impacted by this challenging neurological condition

Which are the best cities for hydrocephalus clinical trials?

When it comes to hydrocephalus clinical trials, several cities have emerged as leading centers for research and innovation. New york, New York is at the forefront with 4 active trials focusing on treatments like Open Shunt Group, Device Arm, and eShunt Implant. Houston, Texas follows closely behind with 2 ongoing studies investigating Phase B and Ventriculoperitoneal Shunt interventions. Additionally, New Haven in Connecticut and Baltimore in Maryland each offer 2 active trials exploring various treatments including Device Arm, eShunt Implant, Open Shunt Group, and Ventriculoperitoneal Shunt. Lastly, Seattle in Washington also contributes to advancing hydrocephalus care through 2 active trials examining treatments such as Open Shunt Group and Ventriculoperitoneal Shunt. These cities collectively serve as hubs of research where individuals with hydrocephalus can access cutting-edge clinical trials that strive to improve outcomes and quality of life for patients.

Which are the top treatments for hydrocephalus being explored in clinical trials?

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain, is seeing advancements in treatment through clinical trials. One exciting option being explored is the eShunt Implant. This innovative implant shows promise with one active trial dedicated to hydrocephalus and a total of two trials since its inception in 2022. As researchers delve deeper into this field, they strive to provide better solutions for individuals suffering from hydrocephalus and improve their quality of life.

What are the most recent clinical trials for hydrocephalus?

Exciting progress is being made in the field of hydrocephalus research, with recent clinical trials offering promising insights and potential advancements. One study investigates the utilization of continuous antibiotic use until the EVD (external ventricular drain) is removed, aiming to improve outcomes for individuals with hydrocephalus. Another significant trial focuses on evaluating the effectiveness of ventriculoperitoneal shunts as a treatment option for this condition. These trials highlight ongoing efforts to enhance patient care and provide hope for those affected by hydrocephalus.

What hydrocephalus clinical trials were recently completed?

Recently, several clinical trials focusing on hydrocephalus have reached important milestones, highlighting significant progress in the field. Notably, a trial investigating the effectiveness of a new treatment option was successfully completed by researchers. These dedicated efforts underscore the commitment to finding innovative solutions for hydrocephalus and offer hope for individuals living with this condition.